Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs morphine for perioperative neurocognitive outcomes after pancreatic surgery
ChiCTR2400088248Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in perioperative neurocognitive disorder and postoperative pain (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Incidence of postoperative delirium, Incidence of delayed neurocognitive recovery and 1 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
perioperative neurocognitive disorderpostoperative pain
Beyond the preview
Go deeper on ChiCTR2400088248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088248.